Patent · US Active

PDE1 inhibitory compounds and methods

US9763948B2 · kind B2 · utility

7Cited by

33References

5Claims

0Family size

Assignee

INTRA-CELLULAR THERAPIES, INC. · US

Inventors

Peng Li · New York, US
Jun Zhao · New York, US

Key dates

Filing date	May 31, 2011
Grant date	Sep 19, 2017
Priority date	—
Expiry date	May 31, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Optionally substituted (1- or 3-oxy)-4,5,7,8-tetrahydro-(optionally 4-oxo, 4-thioxo or 4-imino)-2H-imidazo[1,2-a]pyrrolo[3,4-e]pyrimidine or (1- or 3-oxy)-4,5,7,8,9-pentahydro-(optionally 4-oxo, 4-thioxo or 4-imino)-2H-pyrimido[1,2-a]pyrrolo[3,4-e]pyrimidine compounds, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.